I live in NASCAR country and it's not that rare to hear the
expression "going checkers or wreckers" - meaning throwing caution to
the wind and going all-out, with the idea that you either win or end up
in a smoking heap.
That notion would seem to apply to Pacific Biosciences (PACB)
today, as this once-promising innovator in single-molecule sequencing
has been battered by concerns about the accuracy and value of its
systems. With intriguing accuracy-improvement technology and techniques
now available, though, PacBio may have its last best chance to achieve
the success that many once thought was near-certain. If PacBio can
recover its reputation and drive system and consumables sales, this
stock could be undervalued by 50% or more. On the other hand, failure to
markedly accelerate customer adoption over the next three years could
have this company in bankruptcy and the share price in tatters.
Read the full article here (subscription required):
Pacific Biosciences Will Go Checkers Or Wreckers
No comments:
Post a Comment